Sure. Good morning, Mac. Thanks for the question. I think it’s important to understand kind of where we are. We have very attractive partners in each of our verticals now, bus, truck, rail and marine, off-road, stationary, blue-chip partners, blue-chip programs, demonstration programs underway. And where we are also in the development of our own technology and products, we’re really maturing, in some cases, from concept level to prototype, et cetera. And as you get deeper into these product development programs, the investments get heavier. So, we have a number of programs that we’ll be effectively investing in, both at the stack and module level. And stack and module programs, we’re trying to focus on core products where we can rationalize market and product requirements from all these different verticals and the different geographics by core fuel cell technology, MEAs, bipolar plates, stacks obviously, and modules, including the module architecture. And I think it’s important that the testing and design validation, as I said, as you get into the maturing from -- into prototype and even beyond in the series, it’s just a deeper investment. So, I think those are important. And we also are -- I think, about an 80% increase in research in 2022. And that’s continuing our investment in core MEA components, catalyst, GDL membrane as well as pretty significant investment in balance of plant components. So HRB, air compressor, DC, DC converters with partners in these cases, but it does require investment in Ballard as well. On the CapEx front, pretty significant investment coming in our testing capability, so about 22 new test stations and some 48 test stations that are going through upgrades in 2022. So, it’s a fairly significant investment year on the testing capability side. And then, we have very significant investment on the production equipment, both for next-generation plate pilot line project that we’re working on as I mentioned earlier as well as continued manufacturing process improvements across MEAs and modules as well. Significant investment on the CapEx side for lab and engineering equipment, upgrades on our facilities and tooling and fixtures. And on the tooling and fixture side, pretty significant investment for balance-of-plant component cost reduction and some of the tooling we need also for our new unit cell designs at the stack level, so -- at the unit cell level. So, a pretty significant investment overall. And we’re making that investment because all of these different markets that we’re involved in, again, we are, I think, going through this process where we’re transitioning from customer acquisition, from platform wins to long-term supply agreements. And we’re readying with a lot of customer interest on understanding how we’re scaling to support their expected growth.